Source: http://www.law.cornell.edu/cfr/text/42/8?quicktabs_7=1
Timestamp: 2013-12-20 02:15:08
Document Index: 709123915

Matched Legal Cases: ['art 8', '§ 8', '§ 8', '§ 8', 'art 8', '§ 823', '§ 257', '§ 290', '§ 290', '§ 300', '§ 300', '§ 300']

42 CFR 8 - CERTIFICATION OF OPIOID TREATMENT PROGRAMS | Title 42 - Public Health | Code of Federal Regulations | LII / Legal Information Institute
CFR › Title 42 › Chapter I › Subchapter A › Part 8	prev | next
42 CFR 8 - CERTIFICATION OF OPIOID TREATMENT PROGRAMS
There is 1 rule appearing in the Federal Register for 42 CFR 8. Select the tab below to view, or View eCFR (GPOAccess)
SUBPART A — Accreditation (§§ 8.1 - 8.6)
SUBPART B — Certification and Treatment Standards (§§ 8.11 - 8.15)
SUBPART C — Procedures for Review of Suspension or Proposed Revocation of OTP Certification, and of Adverse Action Regarding Withdrawal of Approval of an Accreditation Body (§§ 8.21 - 8.34)
Authority: 21 U.S.C. 823; 42 U.S.C. 257a, 290aa(d), 290dd-2, 300x-23, 300x-27(a), 300y-11.
Source: 66 FR 4090, Jan. 17, 2001, unless otherwise noted.
Title 42 published on 2012-10-01The following are only the Rules published in the Federal Register after the published date of Title 42.For a complete list of all Rules, Proposed Rules, and Notices view the Rulemaking tab.2012-12-06; vol. 77 # 235 - Thursday, December 6, 201277 FR 72752 - Opioid Drugs in Maintenance and Detoxification Treatment of Opiate Addiction; Proposed Modification of Dispensing Restrictions for Buprenorphine and Buprenorphine Combination as Used in Approved Opioid Treatment Medications
typeregulations.gov FR Doc.2012-29417 RIN0930-AA14 DEPARTMENT OF HEALTH AND HUMAN SERVICES, Substance Abuse and Mental Health Services Administration (SAMHSA) Final rule. This rule is effective January 7, 2013. 42 CFR Part 8 SummaryThis final rule amends the federal opioid treatment program regulations by modifying the dispensing requirements for buprenorphine and buprenorphine combination products approved by the Food and Drug Administration (FDA) for opioid dependence and used in federally certified and registered opioid treatment programs. In particular, this rule would allow opioid treatment programs more flexibility in dispensing take-home supplies of buprenorphine—removing restrictions on the time a patient needs to be in treatment in order to receive take-home supplies—after the assessment and documentation of a patient&apos;s responsibility and stability to receive opioid addiction treatment medication. Opioid treatment programs that use these products in the treatment of opioid dependence will continue to adhere to all other federal treatment standards established for methadone.
This is a list of United States Code sections, Statutes at Large, Public Laws, and Presidential Documents, which provide rulemaking authority for this CFR Part.This list is taken from the Parallel Table of Authorities and Rules provided by GPO [Government Printing Office].It is not guaranteed to be accurate or up-to-date, though we do refresh the database weekly. More limitations on accuracy are described at the GPO site.United States CodeUSC : Title 21 - FOOD AND DRUGS§ 823 - Registration requirements
U.S.C. : Title 42 - THE PUBLIC HEALTH AND WELFARE§ 257a - Transferred§ 290aa - Substance Abuse and Mental Health Services Administration42 USC § 290dd–2 - Confidentiality of records42 USC § 300x–23 - Intravenous substance abuse42 USC § 300x–27 - Treatment services for pregnant women42 USC § 300y–11 - Interim maintenance treatment
Title 42 published on 2012-10-01The following are ALL rules, proposed rules, and notices (chronologically) published in the Federal Register relating to 42 CFR 8 after this date.2012-12-06; vol. 77 # 235 - Thursday, December 6, 201277 FR 72752 - Opioid Drugs in Maintenance and Detoxification Treatment of Opiate Addiction; Proposed Modification of Dispensing Restrictions for Buprenorphine and Buprenorphine Combination as Used in Approved Opioid Treatment Medications